Navigation Links
Rcadia's COR Analyzer Family of Products Receives Second FDA Clearance
Date:9/26/2007

HAIFA, Israel, Sept. 26 /PRNewswire/ -- Rcadia Medical Imaging, Ltd., developer of novel computer-aided diagnostic software, has received a second U.S. Federal Food and Drug Administration (FDA) clearance to market its COR Analyzer family of products, which assists in triaging patients for coronary artery disease (CAD). The new approval includes segmentation of the coronary tree with no human intervention and automatic detection of pathologies in the main coronary arteries.

Coronary artery disease is a major underlying cause for acute chest pain in Emergency Department (ED) patients. Annually, more than 5 million US patients present in the ED with acute chest pain. CT Angiography (CTA) is being rapidly adopted to triage patients in EDs across the U.S. Rcadia's COR Analyzer quickly identifies coronary artery disease and helps exclude patients without coronary arterial disease with a high negative predictive value (NPV). Rcadia's COR Analyzer system uses proprietary image processing algorithms allowing a no human intervention analysis of Coronary CTA studies to characterize patients. While improving ED workflow, it can lead to a more rapid diagnosis, enabling appropriate treatments and avoiding unnecessary delays and invasive tests in patients who do not have coronary artery disease.

"The COR Analyzer is expected to assist the ED staff in reading Coronary CTA studies 24/7. Prioritizing patients with CAD, identifying and characterizing pathologies will save time and improve workflow in the ED as well as the radiology and cardiology departments," commented Shai Levanon, Rcadia CEO.

Coronary CTA studies are sent from the CT scanner to the COR Analyzer and analyzed without human intervention. The COR Analyzer is highly reliable in ruling out coronary artery disease. In analyzing over 350 CTA studies, generated by all four CT manufacturers, the Rcadia COR Analyzer successfully identified coronary artery disease and had a high NPV of over 97%.

"As a result of the COR Analyzer high negative predictive value we are currently finalizing testing of the product and strongly hope to start using it to triage cases that need to be read, alerting the reader which patients are most likely to have coronary arterial disease. Since COR Analyzer automatically marks pathologies; this in turn will make reading cases significantly faster even for the experienced radiologists." added Nathan Peled, MD, Head Department of Radiology at the Lady Davis Carmel Medical Center in Haifa.


'/>"/>
SOURCE Rcadia Medical Imaging, Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Dade Behrings (hsCRP) Tests and BNTM Series Analyzers
2. Analyzers Offer Point-of-Care Lipid Panels
3. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Urinalysis Analyzers: Large Capabilities in Every Size Device
6. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
7. PromegaExpress Expands Easy Access to Products with New Cabinet
8. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
9. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
10. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
11. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 A ReportsnReports.com report says, over the ... as the global sales of Adcetris and Kadcyla have been witnessing ... drug conjugates market is driven by large number of ADC drugs ... window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 Major Company Profiles, ...
(Date:3/24/2017)... INDIANAPOLIS , March 24, 2017  Eli ... today announced plans to invest $850 million in ... span facilities across its U.S. enterprise, including research ... The investments are being driven by demand for ... of potential medicines in development targeting cancer, pain, ...
(Date:3/24/2017)... The Board of Directors of Nordic Nanovector ASA (OSE: ... complete 2016 Annual Accounts with notes. The report is attached ... the section Investor Relations/Reports and presentations/Annual Reports. ... For further information, please ... Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com Media enquiries: ...
Breaking Medicine Technology:
(Date:3/25/2017)... ... ... Swissray is pleased to announce the release of the ELITE DXA, a new bone ... scan window, which is more than double that of existing bone densitometers. Historically, subjects ... an accurate total body bone density or body composition study. The ELITE DXA ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease affects billions of ... United States, it’s a threat that is constantly changing and evolving. Mediaplanet's “Fighting ... offers strategies for the healthcare community to help decrease the number of completely ...
(Date:3/24/2017)... Antonio, TX (PRWEB) , ... March 24, 2017 , ... ... new clinic which can be found at 9618 Huebner Road. The clinic is the ... PT, OCS, Clinic Director, and Dr. Ali Higgins, PT, will provide care from the ...
(Date:3/24/2017)... ... March 24, 2017 , ... In just ... EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the $100,000 milestone ... with nearly 2,000 consumers (and counting) already backing the campaign. , “We ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, Scanlan ... to announce Westchester resident Lauren C. Enea has joined the firm as an associate ... concentrate her practice in elder law, Medicaid planning and applications, and Wills, Trusts and ...
Breaking Medicine News(10 mins):